Published in Ter Arkh on January 01, 1990
The sequences homologous to major interspersed repeats B1 and B2 of mouse genome are present in mRNA and small cytoplasmic poly(A) + RNA. Nucleic Acids Res (1982) 1.40
Biosynthesis and cytoplasmic distribution of small poly(A)-containing B2 RNA. Biochim Biophys Acta (1985) 1.16
[Rosenthal's syndrome (hemophilia C) in a patient with psoriatic arthritis (a clinical case)]. Ter Arkh (1997) 0.85
Molecular pathogenesis of systemic lupus erythematosus. Arch Virol (1975) 0.85
[Cardiolipin antibodies in acute rheumatic fever]. Klin Med (Mosk) (1992) 0.82
[Changes in the indicators of bone marrow and blood based on the complex cytological examination of 28 children from the Bryansk region 1 year after the accident at the Chernobyl atomic power plant]. Gematol Transfuziol (1991) 0.82
[Aseptic necrosis of the temporomandibular joint in systemic lupus erythematosus]. Stomatologiia (Mosk) (1999) 0.81
[Role of obesity in the development of osteoarthrosis and concomitant diseases]. Ter Arkh (2010) 0.81
Natural hidden antibodies reacting with DNA or cardiolipin bind to thymocytes and evoke their death. FEBS Lett (1997) 0.80
[Tuberculosis of the lungs complicated by opisthorchiasis under conditions of the extreme north]. Probl Tuberk (1989) 0.79
[Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease]. Ter Arkh (2004) 0.79
[Madecassol treatment of systemic and localized scleroderma]. Ter Arkh (1998) 0.79
[Radioprotective effect of synthetic immunomodulators on hemopoietic CFU-S]. Radiats Biol Radioecol (1994) 0.79
Cytogenetic adaptive response in cultured human lymphocytes: dependence on the time of exposure to adapting and challenging doses of gamma-rays. Mutat Res (1998) 0.78
[Clinical significance of determining antibodies to poly A: poly U in systemic lupus erythematosus]. Ter Arkh (1972) 0.78
[Neutralisation of interferon gamma--a new trend in therapy of rheumatoid arthritis]. Ter Arkh (2008) 0.78
[Tramadol in the vascular pains of patients with systemic scleroderma and other rheumatic diseases]. Ter Arkh (1994) 0.78
[Results of the multicenter clinical trial of structum preparation in Russia]. Ter Arkh (2001) 0.78
[Synovial membrane in the early stage of rheumatoid arthritis: clinico-morphological comparisons]. Ter Arkh (2003) 0.78
[Clinical factors essential for dental caries intensity in rheumatic patients]. Stomatologiia (Mosk) (2002) 0.78
Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies. Clin Diagn Lab Immunol (1997) 0.77
[Ribosomal repeat in the cell free DNA as a marker for cell death]. Biomed Khim (2008) 0.77
Subjective disease experience in Sjögren's syndrome. A computerized discrimination analysis. Scand J Rheumatol (1989) 0.77
[Determination of DNA-binding proteins by countercurrent isotachopheresis on nitrocellulose membranes. I. Antibodies to DNA and its adducts]. Mol Biol (Mosk) (1995) 0.77
[Radiosensitizing effect of interferon synthesis inducers]. Radiobiologiia (1986) 0.77
[Yersinia infections and acute surgical diseases of the organs of the abdominal cavity]. Khirurgiia (Mosk) (1989) 0.77
[Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus]. Kardiologiia (2002) 0.77
[Pulse therapy with methylprednisolone and cyclophosphamide in systemic juvenile rheumatoid arthritis: the results of an open, parallel, controlled, randomized, 12-month study]. Ter Arkh (1992) 0.77
[The hypophyseal-testicular system in cryptorchism patients following surgical treatment]. Probl Endokrinol (Mosk) (1990) 0.76
[The mechanisms of lymphoid regulation and the radiosensitivity of the hematopoietic system]. Radiobiologiia (1992) 0.76
[Soluble adhesion molecules (P-selectin, ICAM-1 and ICAM-3) in rheumatoid arthritis]. Ter Arkh (1999) 0.76
[Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome]. Klin Med (Mosk) (1998) 0.76
[The assessment of left ventricular diastolic function in patients with systemic scleroderma by radionuclide ventriculography]. Ter Arkh (1995) 0.76
[Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma]. Revmatologiia (Mosk) (1991) 0.76
[Induction by formaldehyde of conformational changes from helix to globule in the myoglobin molecule]. Mol Biol (Mosk) (1983) 0.76
["Masked" autoantibodies from the serum of healthy blood donors cross-reacting with DNA and bacterial lipopolysaccharides]. Biull Eksp Biol Med (1991) 0.76
[Familial systemic scleroderma: a follow-up study of concordant monozygotic twins]. Ter Arkh (1981) 0.76
[Differential diagnosis of Wegener's granulomatosis and extranodal NK/T-cell lymphoma, nasal type]. Ter Arkh (2012) 0.76
[Increase in the level of metallothioneins in mouse liver after administration of cadmium chloride does not protect from combined radiation-thermal injury]. Radiats Biol Radioecol (2002) 0.75
[Antibodies to viral antigens in rheumatoid arthritis]. Sov Med (1976) 0.75
[Genetic aspects of rheumatic diseases]. Vestn Akad Med Nauk SSSR (1976) 0.75
[Cytogenetic study of patients with rheumatism in the process of aspirin therapy]. Ter Arkh (1972) 0.75
[Development of the field of "major" collagenoses (diffuse diseases of the connective tissue) in the USSR]. Vopr Revm (1970) 0.75
[Current aspects of the viral etiology of systemic lupus erythematosus]. Vestn Akad Med Nauk SSSR (1975) 0.75
[Current data on the etiology of systemic lupus erythematosus]. Klin Med (Mosk) (1972) 0.75
[Characteristics of autoimmune disorder in systemic lupus erythematosus]. Ter Arkh (1974) 0.75
[Excretion of beta-aminoisobutyric acid in health, in systemic lupus erythematosus and leukemia]. Vopr Med Khim (1969) 0.75
[Clinical and pathogenetic patterns in chronic rheumatic inflammation]. Vestn Akad Med Nauk SSSR (1979) 0.75
[Basic results of scientific study on the problem of rheumatism and joint diseases for 1970]. Vopr Revm (1972) 0.75
[Controlled (double-blind) trial of levamisole in rheumatoid arthritis]. Ter Arkh (1980) 0.75
[Fulfillments of the problem-related plan concerning "Rheumatism and joint diseases" in 1974]. Vopr Revm (1976) 0.75
[Determination of antilymphocytic antibodies in systemic lupus erythematosus by indirect immunofluorescence technic using fixed lymphocytes]. Ter Arkh (1979) 0.75
[Plan for scientific research into the problem of rheumatology in 1979]. Vopr Revm (1979) 0.75
[Basic principles of differentiated therapy of patients with "major" collagenoses]. Vopr Revm (1970) 0.75
[Main results of carrying out the problem-oriented thematic plan of scientific research in rheumatology in 1971-1975]. Vopr Revm (1977) 0.75
[Clinico-immunological characteristics in Felty's syndrome]. Ter Arkh (1980) 0.75
[Characteristic and distribution of antibodies, interacting with single-strand DNA]. Vestn Akad Med Nauk SSSR (1967) 0.75
[Clinico-immuno-morphological characteristics of the early period of systemic lupus erythematosus]. Sov Med (1974) 0.75
[Anti-measles antibodies in systemic lupus erythematosus]. Sov Med (1972) 0.75
[Antibodies to desoxyribonucleic acid (DNA) in diffuse connective tissue diseases]. Ter Arkh (1972) 0.75
[Aseptic bone necrosis in systemic lupus erythematosus and related diseases]. Ter Arkh (1980) 0.75
[Problems of prophylactic examination of patients with rheumatic diseases]. Ter Arkh (1977) 0.75
[Basic problems of the early diagnosis and nosology of connective tissue diseases]. Vopr Revm (1972) 0.75
[Main results of the research in rheumatology during 1978]. Vopr Revm (1980) 0.75
[Ultrastructural data on the immune-complex nature of vascular lesions in systemic lupus erythematosus]. Ter Arkh (1980) 0.75
[Clinico-pathogenetical characteristics of rheumocarditis with minimal activity]. Kardiologiia (1975) 0.75
[Human lymphocyte chromosome reaction to single and fractionated gamma irradiation at different stages of the mitotic cycle]. Radiobiologiia (1980) 0.75
[Catabolic enzymes of the connective tissue in clinical aspects and pathogenesis of lupus-nephritis]. Sov Med (1974) 0.75
[Scientific and organizational problems in the development of rheumatology]. Sov Zdravookhr (1980) 0.75
[Clinical variants in the course and activity of lupus nephritis]. Ter Arkh (1971) 0.75
[Problems in the treatment of joing diseases (according to data of the 4th Congress of Rheumatologists GDR, Weimar, September 11-13, 1974)]. Ter Arkh (1975) 0.75
[Clinical importance of determination of acid phosphatases and cathepsins in the urine of patients with systemic lupus erythematosus]. Ter Arkh (1977) 0.75
[Atypical form of rheumatoid arthritis bordering systemic lupus erythematosus]. Ter Arkh (1974) 0.75
[Plan for research on the problem of rheumatology in 1980]. Vopr Revm (1980) 0.75
[Virological study of the blood in systemic lupus erythematosus]. Vopr Virusol (1975) 0.75
[Use of I125 labelled poly(I). poly(C) for determination of antibodies to double-stranded RNA by immune complex absorption to nitrocellulose filters]. Mol Biol (Mosk) (1976) 0.75
[Digestive organs and systemic connective tissue diseases]. Klin Med (Mosk) (1979) 0.75
[Urgent problems of modern rheumatology]. Ter Arkh (1975) 0.75
[Serum proteins reacting with DNA and DNA-RNA hybrids in New Zealand mice of different ages]. Dokl Akad Nauk SSSR (1980) 0.75
[New data on the etiology and pathogenesis of rheumatism]. Ter Arkh (1976) 0.75
[Results of long-term observations of systemic lupus erythematosus patients]. Ter Arkh (1968) 0.75
[Diagnostic criteria of systemic lupus erythematosus]. Sov Med (1980) 0.75
Interactions of protein (antibodies) with the deoxyribonucleic acid molecule. Nature (1966) 0.75
[External respiration in patients with systemic lupus erythematosus]. Ter Arkh (1967) 0.75
[Some problems in the prevention of streptococcal infections]. Ter Arkh (1974) 0.75
[Remote results of corticosteroid therapy in systemic lupus erythematosus]. Ter Arkh (1979) 0.75
[Determination of antibodies to DNA using radioimmunological methods and passive hemagglutination reaction in patients with systemic diseases of the connective tissue]. Sov Med (1976) 0.75
[Emergency situations in rheumatology]. Sov Med (1972) 0.75
[Differentiated leukocyturia in lupus-nephritis]. Sov Med (1973) 0.75
[Immunological aspects of the study of rheumatoid arthritis]. Ter Arkh (1976) 0.75
[Collagen diseases and tuberculosis, their combinations and masks]. Probl Tuberk (1967) 0.75
[Treatment of rheumatoid arthritis with prolonged-action drugs]. Klin Med (Mosk) (1980) 0.75